Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 11. 9. 2020, under the no. SUKLS209004/2019:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 30. 10. 2020, under the no. SUKLS107156/2020:

• the operative parts 2b and 4b of the decision under appeal is reversed and the issue is referred back for reappraisal.
  
• The rest of the decision under appeal is upheld

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 4. 11. 2020, under the no. SUKLS208996/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 30. 6. 2020, under the no.: SUKLS208984/2019:

• the operative parts 2 and 3 of the decision under appeal is reversed and the proceedings are terminated.
• The rest of the decision under appeal is upheld

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 14. 7. 2020, under the no. SUKLS46482/2017:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 11. 9. 2020, under the no. . SUKLS50203/2020:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 2. 7. 2020, under the no: SUKLS237346/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant s Teva Pharmaceuticals CR, s.r.o. and Merck Europe B.V., against the decision of the State Institute for Drug Control from 24. 2. 2022, under the no.: SUKLS81849/2014:

• the operative parts 7 and 8 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal
• The rest of the decision under appeal is upheld

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 2. 7. 2020, under the no: SUKLS237346/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 2. 7. 2020, under the no: SUKLS237365/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance Companies, against the decision of the State Institute for Drug Control from 2. 7. 2020, under the no: SUKLS209077/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 19. 8. 2020, under the no: SUKLS142608/2020:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant BAYER AG, against the decision of the State Institute for Drug Control from 27. 5. 2020, under the no: SUKLS333738/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 25. 6. 2020, under the no: SUKLS92178/2020:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant BAYER AG, against the decision of the State Institute for Drug Control from 27. 5. 2020, under the no: SUKLS331494/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant NOVO NORDISK A/S, against the decision of the State Institute for Drug Control from 8. 8. 2022, under the no: SUKS122582/2022:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.